or Try an Advanced Search...

    Technical Analysis for CMND - Clearmind Medicine Inc.

    Grade Last Price % Change Price Change
    F 1.21 0.00% 0.00
    CMND closed unchanged on Wednesday, April 24, 2024, on 5 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical CMND trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Up 3 Days in a Row Strength 0.00%
    Crossed Above 20 DMA Bullish 1.68%
    Bollinger Band Squeeze Range Contraction 1.68%
    Inside Day Range Contraction 1.68%
    Older End-of-Day Signals for CMND ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 19 hours ago
    Possible NR7 about 20 hours ago
    Possible Inside Day about 20 hours ago
    20 DMA Resistance about 22 hours ago
    Down 3% about 24 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CMND Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.
    Classification
    Keywords: Biotechnology Health Sciences Medication

    Is CMND a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 17 Clearmind signs agreement for psychedelic compounds for mental disorders treatment
    Apr 17 Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
    Apr 9 Clearmind Medicine CEO Issues Letter to Shareholders
    Mar 30 Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
    Mar 27 Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
    Mar 20 Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
    Mar 19 Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
    Mar 16 Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
    Mar 13 Clearmind Medicine receives nod for delisting of shares from Canadian Securities Exchange
    Mar 13 Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
    See more CMND news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 23.7
    52 Week Low 0.9205
    Average Volume 552,947
    200-Day Moving Average 5.07
    50-Day Moving Average 1.34
    20-Day Moving Average 1.19
    10-Day Moving Average 1.22
    Average True Range 0.11
    RSI (14) 46.81
    ADX 14.0
    +DI 17.17
    -DI 13.89
    Chandelier Exit (Long, 3 ATRs) 1.05
    Chandelier Exit (Short, 3 ATRs) 1.38
    Upper Bollinger Bands 1.31
    Lower Bollinger Band 1.07
    Percent B (%b) 0.58
    BandWidth 19.77
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0121
    Fundamentals Value
    Market Cap 3.84 Million
    Num Shares 3.17 Million
    EPS -31.63
    Price-to-Earnings (P/E) Ratio -0.04
    Price-to-Sales 0.00
    Price-to-Book 6.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.29
    Resistance 3 (R3) 1.28 1.24 1.27
    Resistance 2 (R2) 1.24 1.22 1.25 1.27
    Resistance 1 (R1) 1.23 1.21 1.24 1.24 1.26
    Pivot Point 1.19 1.19 1.20 1.20 1.19
    Support 1 (S1) 1.18 1.17 1.19 1.19 1.16
    Support 2 (S2) 1.14 1.16 1.15 1.15
    Support 3 (S3) 1.13 1.14 1.15
    Support 4 (S4) 1.14